XENE
NASDAQ · Biotechnology
Xenon Pharmaceuticals Inc
$64.17
-0.13 (-0.20%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+51.24%
1Y
+90.81%
YTD
+44.23%
Open$64.50
Previous Close$64.30
Day High$65.49
Day Low$64.05
52W High$72.66
52W Low$30.00
Volume—
Avg Volume673.8K
Market Cap6.41B
P/E Ratio—
EPS$-4.70
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$42.54
Above
SMA 200
$37.78
Above
RSI (14)
57.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
26 analysts
Price Target
-68.9% upside
Current
$64.17
$64.17
Target
$19.98
$19.98
$12.55
$19.98 avg
$22.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.68M | 10.45M | 1.14B |
| Net Income | -446,666,171 | -433,890,506 | -213,860,892 |
| Profit Margin | -4,612.1% | -4,381.5% | -18.8% |
| EBITDA | -478,452,478 | -490,588,077 | -248,558,556 |
| Free Cash Flow | — | — | -268,893,932 |
| Rev Growth | -7.4% | -7.4% | +15.1% |
| Debt/Equity | — | — | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $244.33 | -0.76% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $403.48 | -1.07% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $129.97 | -1.36% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $767.54 | -0.14% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.83 | -4.76% | 47.7 | 27.52B |